Lab
Biodx Labs
Biodx Labs was paid $1.94M by Medicaid between May 2022 and Nov 2023, across 5 billing codes. Its largest line is 87913, — 74% of everything it billed.
33Billing provider infoBIODX LABS
COPPELL, TX 75019
COPPELL, TX 75019
33aNPI1366193088assigned 01/13/2022
33bProvider typeClinical Medical Laboratory
28Total paid$1.94M
24GClaims16,838
24DCodes billed5
24AFirst – last monthMay 2022 – Nov 2023
Compared with peers
Next to other Clinical Medical Laboratory providers in Texas
Rank by total paid#45 of 436
Median peer was paid$17K
This provider vs. median112×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 192 | $3K | |
| 2023 | 16,646 | $1.93M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87913 | 74% | 6,973 | 6,950 | $1.43M | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 26% | 9,673 | 6,861 | $505K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 64 | 56 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 64 | 56 | $522.50 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 64 | 56 | $490.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOSMAN, SYED (OWNER)